WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2016

Feb 24, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2016-02-22

Reporting Person: Bedwell Warwick (President, Pharma Pkgs Systems)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-02-22	Common Stock	M	9458.0000	$21.2200	Acquired	43623.0820	Direct
2016-02-22	Common Stock	M	6584.0000	$29.5550	Acquired	50207.0820	Direct
2016-02-22	Common Stock	S	6584.0000	$59.5182	Disposed	43623.0820	Direct
2016-02-22	Common Stock	S	9458.0000	$59.5182	Disposed	34165.0820	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-02-22	Stock Option (Right to Buy)	$29.5550	M	6584.0000	Disposed	2023-02-19	Common Stock (6584.0000)	Direct
2016-02-22	Stock Option (Right to Buy)	$21.2200	M	9458.0000	Disposed	2022-02-21	Common Stock (9458.0000)	Direct

Footnotes

F1: This was multiple transactions on the same date with prices in the range of $59.33to $59.845. The undersigned hereby undertakes to provide upon request to the Securities and Exchange Commission, the issuer or any security holder of the issuer on request, full information regarding the number of shares purchased or sold at each separate price.

F2: This was multiple transactions on the same date with prices in the range of $59.33 to $59.845. The undersigned hereby undertakes to provide upon request to the Securities and Exchange Commission, the issuer or any security holder of the issuer on request, full information regarding the number of shares purchased or sold at each separate price.